Meeting
2017 ASCO Annual Meeting
Evaluation of stored liquid biopsies for molecular profiling in patients with non-small cell lung cancer (NSCLC).
Authors
Penelope Ann Bradbury
Princess Margaret Cancer Centre, Toronto, ON, Canada
Penelope Ann Bradbury , Keyue Ding , Peter Michael Ellis , Lesley Seymour , Frank De Kievit , Greg Jones , Clive D. Morris , Emma Green , Glenwood D. Goss , Ming Sound Tsao , Frances A. Shepherd
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 9024)
DOI
10.1200/JCO.2017.35.15_suppl.9024
Abstract #
9024
Poster Bd #
350
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Evaluation of liquid biopsies for molecular profiling in patients with advanced non-small cell lung cancer (NSCLC) in the relapse treatment setting.
First Author: Jordi Remon
Poster
2023 ASCO Annual Meeting
LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer.
First Author: Aurélie Swalduz
Poster
2022 ASCO Annual Meeting
Afatinib (AFA) plus bevacizumab (BEV) combination after osimertinib (OSI) resistance in advanced EGFR-mutant NSCLC: A phase II study (ABCD-study).
First Author: Akito Hata
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates